2002-11-01 - Male - 12 Years old
155446
| Adverse reaction report number | 155446 |
| Latest AER version number | 0 |
| Market authorization holder AER number | CND0200100 |
| Initial received date | 2002-11-01 |
| Latest received date | 2002-11-01 |
| Age | 12 Years |
| Gender | Male |
| Weight | N/A |
| Type of report | Special Access Program |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | MAH |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 30 Milligram | every 1 Day(s) | ||
| CLONIDINE | NOT SPECIFIED | Concomitant | Unknown | 0.125 Milligram | every 1 Day(s) | ||
| NEURONTIN | NOT SPECIFIED | Concomitant | Unknown | 200 Milligram | |||
| RISPERDAL | NOT SPECIFIED | Concomitant | Unknown | 1.75 Milligram | every 1 Day(s) | ||
| SERZONE-5HT2 | TABLET | Concomitant | Unknown | 150 Milligram | every 1 Day(s) |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Mood swings | |